Nanomix Corporation (NNMX)

OTCMKTS: NNMX · Delayed Price · USD
0.250
0.00 (0.00%)
Feb 2, 2023, 1:50 PM EST - Market closed
Market Cap 9.26M
Revenue (ttm) -126,328
Net Income (ttm) -11.47M
Shares Out 48.48M
EPS (ttm) -0.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,200
Open 0.250
Previous Close 0.250
Day's Range 0.250 - 0.250
52-Week Range 0.020 - 10.000
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Apr 10, 2023

About NNMX

Boston Therapeutics, Inc. develops, manufactures, and commercializes therapeutic drugs to address unmet medical needs in diabetes and inflammatory diseases. The company develops BTI-320, a non-systemic carbohydrate-based compound tablet that is in Phase II clinical trial for reduction of post-meal blood glucose levels in pre-diabetes patients and type 2 diabetes patients; and IPOXYN, an injectable drug to prevent necrosis, as well as to treat hypoxic conditions, such as diabetic foot ulcers and other vascular/neurological complications. It is a... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2000
Employees 25
Stock Exchange OTCMKTS
Ticker Symbol NNMX
Full Company Profile

Financial Performance

Financial Statements

News

Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer

SAN LEANDRO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care (POC) diagnostics, today announced ...

1 week ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy

SAN LEANDRO, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

2 months ago - GlobeNewsWire

Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.

SAN LEANDRO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

3 months ago - GlobeNewsWire

Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited

SAN LEANDRO, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

3 months ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile

SAN LEANDRO, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

3 months ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East

SAN LEANDRO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, to...

5 months ago - GlobeNewsWire

Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies

Point-of-care technology to offer patients a timely, highly accurate status of their protection against COVID-19 Point-of-care technology to offer patients a timely, highly accurate status of their pr...

5 months ago - GlobeNewsWire

Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D.

SAN LEANDRO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, tod...

5 months ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with BIOASIA PTE LTD in Singapore

SAN LEANDRO, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, tod...

5 months ago - GlobeNewsWire

Nanomix Announces ISO 13485:2016 Certification for its New Facility in San Leandro, CA

SAN LEANDRO, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced that i...

6 months ago - GlobeNewsWire

Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger as Chief Executive Officer and Member of the Board of Directors

SAN LEANDRO, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced the ap...

6 months ago - GlobeNewsWire

Nanomix Announces Distribution Agreement for the eLab System with Biotron Ltd. in Israel

SAN LEANDRO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, tod...

7 months ago - GlobeNewsWire

Nanomix Initiates New Clinical Study for the eLab S1 Panel

Study incorporates the use of the Nanomix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in Madrid, Spain Study incorporates the use of the Nanomix eLab® S1 Panel within...

8 months ago - GlobeNewsWire

Nanomix Receives IVDR Certification for the eLab Analyzer

IVDR certification enables Nanomix to market its eLab analyzer in the European Union under the newly established regulatory guidelines IVDR certification enables Nanomix to market its eLab analyzer in...

8 months ago - GlobeNewsWire

Nanomix Granted CE Mark for eLab S1 Assay Panel for Whole Blood Samples

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today...

9 months ago - GlobeNewsWire

Nanomix Announces Upgrade to OTCQB® Venture Market

EMERYVILLE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, is pl...

9 months ago - GlobeNewsWire

Nanomix Receives CE Mark for its eLab COVID-19 Rapid Point-of-Care Antigen Panel

EMERYVILLE, Calif, May 20, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCBB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today ...

9 months ago - GlobeNewsWire